FIB-4 Index, Systemic Inflammation, and Troponin Trajectory After Endovascular Thrombectomy in Older Patients with

Wenjie Chen1, Yahang Tan1, Xuesong Bai2

  • 1Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.

Insights

The Fibrosis-4 (FIB-4) index and C-reactive protein (CRP) indicate higher myocardial injury risk after large-vessel occlusion acute ischemic stroke (LVO-AIS). Dynamic myocardial injury predicts increased 90-day mortality in these stroke patients.

Area of Science:

  • Cardiology
  • Neurology
  • Biochemistry

Background:

  • Stroke-heart syndrome complicates prognosis in large-vessel occlusion acute ischemic stroke (LVO-AIS).
  • The Fibrosis-4 (FIB-4) index may indicate metabolic vulnerability, but its link to post-stroke myocardial injury and inflammation's role is unclear.

Purpose of the Study:

  • To investigate the association between the FIB-4 index, C-reactive protein (CRP), and myocardial injury in LVO-AIS patients.
  • To explore the modifying effect of systemic inflammation on the FIB-4 index-myocardial injury relationship.
  • To assess the association between myocardial injury patterns and 90-day mortality.

Main Methods:

  • Retrospective cohort study of 448 patients (≥60 years) with anterior-circulation LVO-AIS treated with endovascular thrombectomy.
  • Cardiac troponin I levels measured at admission and 48 hours to classify troponin trajectory (no, non-dynamic, or dynamic myocardial injury).
  • Ordinal and binary logistic regression analyses used to assess associations of FIB-4, CRP, and 90-day mortality.

Main Results:

  • Higher FIB-4 index and elevated CRP were significantly associated with more severe troponin trajectories.
  • Systemic inflammation (indicated by CRP) modified the association between high FIB-4 and troponin trajectory.
  • Dynamic myocardial injury was linked to a substantially increased risk of 90-day mortality.

Conclusions:

  • Elevated FIB-4 index and CRP levels are associated with increased myocardial injury severity in LVO-AIS patients.
  • Systemic inflammation plays a role in the relationship between FIB-4 and myocardial injury.
  • Identifying dynamic myocardial injury is crucial for predicting mortality risk in LVO-AIS.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...